Dr. Juan Pablo Márquez Manríquez, was an immunological oncologist and clinical researcher, who, during his work at the University of Washington in Seattle, sought the development of a vaccine against certain types of cancer.
The renowned Mexican doctor born in Cajeme, Sonora, died earlier this year after pulmonary complications. Dr. Juan Pablo Márquez, was a medical oncologist and immunologist who developed various clinical research projects for the prevention of gastrointestinal tumors related to colon and pancreatic cancer.
Dr. Márquez, carried out his training in Mexico at the Autonomous University of Coahuila and at the National Autonomous University of Mexico where he studied the careers of Pharmaceutical Chemist Biologist and medicine, respectively. In the United States, he completed his residency in internal medicine at the University of California and a specialty in Medical Oncology and a subspecialty in clinical immunology at the University of Washington. It was in Seattle where he developed projects related to the prevention of gastrointestinal cancer.
Since 2002, he has been involved in various international scientific conferences organized by important organizations such as the American Association for Cancer Research, the American Society for Clinical Oncology, among others.
Dr. Márquez was also the director of the the Binational Immuno-Oncology Alliance of Seattle and Sonora and and was a central part of the creation of the Center for Cancer Research in Sonora (CICS).
The collaboration between the CICS and the University of Washington allowed the creation of a research program called CancerVac and Vaccine Institute Project, with the objective of developing preventive vaccines for the types of cancer with the highest prevalence worldwide, in addition to being able to avoid subsequent complications in people who they already suffered from this disease.
Márquez Manríquez explained that the first vaccines that could be obtained thanks to this association are those to prevent five types of cancer: ovarian, lung, multiple myeloma, colorectal and prostate. "In 2006 we did a pilot study in Sonora with 25 patients with ovarian cancer, 25 colon, 25 multiple myeloma and 25 breast," explained the specialist from Sonora.
Today we remember his great contribution to medicine thanks to his research.
ONCOLOGÍA MOLECULAR
https://oncologiamolecular.com.mx/equipo-medico
EL IMPARCIAL
INFOCAJEME
https://www.infocajeme.com/general/2021/01/fallece-el-dr-juan-pablo-marquez-reconocido-oncologo/
